TheraRadar
← Back
Data updated: Jun 28, 2026

VISUM PHARM

Generics
Pharmaceuticals

VISUM PHARM is a generic drug manufacturer with 1 FDA-approved products.

2018
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

VISUM PHARM's Key Drugs

VISUM PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

VISUM PHARM's Recent FDA Approvals

New NDA/BLA approvals for VISUM PHARM over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

VISUM PHARM's Therapeutic Areas

Disease areas where VISUM PHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

VISUM PHARM Pipeline Snapshot

Active clinical trials for VISUM PHARM across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling